Health Care: Drugs

Amarin Corporation PLC (AMRN: NASDAQ)

$1.53 -0.08 | -4.97%
04/15/14 - 04:00 PM ET
Company Profile
Price and Volume
Recent Price 1.61
52 Week High 7.98
52 Week Low 1.36
Avg. Daily Vol. (Mil) 3.53
Beta (3 year) 1.17
Share Related Items
Mkt Cap (Mil) 277.63
Shares Out (Mil) 172.44
Float (Mil) 0.00
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 5.20
Current Ratio 5.80
LT Debt/ Equity 0.00
Total Debt / Equity n.a.
Valuation Ratios
Price Earnings n.a.
Price/Sales 10.54
Price/Book 0.00
Price/Cash Flow -1.90
Per Share Data
Earnings -1.03
Sales 0.15
Book Value 0.00
Cash Flow -0.86
Business Summary
Amarin Corporation PLC is a biopharmaceutical company with expertise in lipid science focused on commercialization and development of therapeutics to improve cardiovascular health.
General Information
2 Pembroke House
Upper Pembroke Street 28-32
Dublin, 2
www.amarincorp.com
Industry : Drugs
Sector: Health Care
Employees: 185
CEO: John F. Thero
Short Interest
Current Month (Mil) 27.74
Previous Month (Mil) 27.28
Short Interest Ratio (Days) 10.20
Management Effectiveness
Return on Equity n.a.
Return on Assets -65.80
Return on Investments -77.60
Profitability
Gross Margin 54.80
EBIT Margin n.a.
Profit Margin 0.00

Portfolios with AMRN

Latest AMRN Headlines from TheStreet

More Financial News for AMRN

Press Releases for AMRN

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter